U-Blot® Research Grade FletikumabCat. No. WA2872$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade FletikumabCat. No. WA2872
U-Blot® Research Grade FlanvotumabCat. No. WA2871
U-Blot® Research Grade FiztasovimabCat. No. WA2870
U-Blot® Research Grade firsekibartCat. No. WA2869
U-Blot® Research Grade FirivumabCat. No. WA2868
U-Blot® Research Grade FirastotugCat. No. WA2867
U-Blot® Research Grade FinotonlimabCat. No. WA2866
U-Blot® Research Grade FigitumumabCat. No. WA2865
U-Blot® Research Grade FidasimtamabCat. No. WA2864
U-Blot® Research Grade FiclatuzumabCat. No. WA2863
U-Blot® Research Grade Ficerafusp AlfaCat. No. WA2862
U-Blot® Research Grade FianlimabCat. No. WA2861